Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Karyopharm Therapeutics Inc. | StockGist | StockGist

Companies
KPTI
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings KPTISCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Karyopharm Therapeutics Inc.

Filed Nov 3, 2025

Accepted Nov 2, 2025, 7:00 PM ET

CIK 0001503802

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

4.99%

Shares Owned

15,926,939

Reporting Person

Karyopharm Therapeutics Inc.

Person Type

OO

CUSIP: 48576U205

Amendment History

9 filings

SCHEDULE 13G
Original
Feb 10, 20260001104659-26-012689
SCHEDULE 13G/A
Amendment 1
Oct 17, 20250000019617-25-001004
SCHEDULE 13G/A
Amendment 2
Oct 30, 20250000102909-25-000154
SCHEDULE 13G/A
Amendment 3
Viewing
Nov 3, 20250001493152-25-020601
SCHEDULE 13G/A
Amendment 4
Nov 7, 20250001897612-25-000507
SCHEDULE 13G/A
Amendment 5
Nov 14, 20250000902664-25-004954
SCHEDULE 13G/A
Amendment 6
Jan 29, 20260001315863-26-000103
SCHEDULE 13G/A
Amendment 7
Feb 12, 20260000902664-26-000896
SCHEDULE 13G/A
Amendment 8
Latest
Feb 17, 20260001897612-26-000267

Key Facts

% of Class

4.99%

Shares Owned

15,926,939

Recent Filings

Karyopharm Therapeutics Inc.2 days ago

Karyopharm Therapeutics Inc.1 weeks ago

Karyopharm Therapeutics Inc.1 weeks ago

Karyopharm Therapeutics Inc.1 months ago

Karyopharm Therapeutics Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice